Medical Science Liaison, Molecular Imaging (Cardiac Amyloidosis) - West Coast

Bayer•Residence Based, CA

6d•Remote

About The Position

Bayer is seeking a field-based Medical Science Liaison to serve as a credible scientific partner to healthcare professionals across a designated U.S. territory, with a focus on molecular imaging and cardiac amyloidosis. The role supports compliant scientific exchange across the multidisciplinary amyloidosis ecosystem, including cardiology, hematology/oncology, nuclear medicine, radiology, and integrated amyloidosis centers. The MSL builds peer-to-peer relationships, generates actionable field insights, advances understanding of systemic and cardiac amyloidosis and its diagnostic pathway, supports evidence-generation activities, and contributes to launch-related field capability and institutional readiness. This is a field execution role focused on scientific engagement, insight generation, and cross-functional follow-through. The territory is the West Coast, covering California, Oregon, and Washington. Candidates must reside within the territory. The MSL supports scientific strategy and institutional readiness while working with appropriate technical partners; technical protocol implementation and scanner-specific execution remain with designated technical roles.

Requirements

Advanced clinical or scientific degree, such as PharmD, PhD, MD, DO, DNP, MSN, NP, or PA.
Field-based MSL experience in the pharmaceutical or biotechnology industry.
Ability to critically evaluate and communicate complex clinical and scientific data to expert audiences.
Working knowledge of U.S. compliance requirements governing scientific exchange.
Strong presentation, relationship-building, territory-management, insight-generation, and self-management skills in a remote field role.
Valid driver’s license with a clean driving record.
Residence within the assigned territory near a major airport.
Ability to travel 50–70%, including overnight travel and occasional weekends.

Nice To Haves

Field-medical or clinical experience in cardiology, heart failure, cardiomyopathy, cardiac imaging, or cardiac amyloidosis.
At least 3 years of field-based MSL industry experience.
Established scientific relationships with relevant clinicians and multidisciplinary amyloidosis teams in the territory.
Experience supporting a pre-launch or launch-stage product, particularly in a first-in-class, diagnostic, molecular-imaging, or radiopharmaceutical environment.
Working knowledge of systemic amyloidosis, including ATTR and AL pathways, and the roles of imaging, laboratory assessment, biopsy, specialist referral, and multidisciplinary care.
Experience gathering actionable insights, mapping diagnostic or referral pathways, and supporting evidence-generation or investigator-initiated research programs.
Experience collaborating across Medical Affairs, Clinical Development, HEOR/RWE, Market Access, Regulatory, Medical Information, and technical field functions.
Familiarity with CRM and insight-capture platforms such as Veeva.

Responsibilities

Identify, develop, and maintain compliant, high-value scientific relationships with relevant healthcare professionals and institutional stakeholders.
Conduct balanced, peer-to-peer scientific exchange on systemic and cardiac amyloidosis, diagnostic pathways, clinical evidence, and investigational data in accordance with applicable policies and regulations.
Deliver scientific presentations and disease-state education using approved resources.
Execute a territory engagement plan that prioritizes relationship depth, multidisciplinary institutional reach, and meaningful follow-up.
Gather, document, and communicate timely, high-quality insights about diagnostic and referral pathways, evidence gaps, educational needs, operational readiness, access themes, and barriers to adoption.
Translate field observations into insights that inform Medical strategy, educational planning, evidence priorities, launch preparedness, and cross-functional action.
Map diagnostic pathways and key decision points at priority institutions, including the roles of referring clinicians, imagers, readers, technologists, and multidisciplinary care teams.
Use approved systems to document engagements, insights, follow-up, and territory-plan progress.
Advance scientific understanding of systemic and cardiac amyloidosis, including unmet needs related to underdiagnosis, delayed diagnosis, and complex referral pathways.
Identify institution-specific educational needs and support approved disease-state initiatives, advisory boards, congress activities, and other Medical Affairs programs.
Engage stakeholders across relevant specialties to develop a medically grounded understanding of how patients move through suspicion, referral, imaging, diagnosis, and follow-up.
Support Bayer-sponsored research activities as appropriate, including investigator and site engagement, site identification, and scientific follow-up.
Identify and appropriately triage investigator-initiated research concepts and evidence gaps through established Medical Affairs processes.
Contribute to assigned evidence-generation, publication, congress, medical-resource, or advisory-board workstreams, with clear documentation and follow-through.
Assess priority-center readiness and identify gaps related to referral pathways, scientific understanding, readers, technologists, workflow, or infrastructure.
Route identified readiness gaps to the accountable function and monitor follow-up through approved processes.
Collaborate with Molecular Imaging Specialists and other authorized partners while maintaining clear role boundaries.
Collaborate with Medical Information, Medical Communications, HEOR/RWE, Commercial, Clinical Development, Regulatory Affairs, Market Access, and other cross-functional partners in compliance with applicable policies and requirements.
Support internal scientific training on disease state, diagnostic pathways, and clinical evidence as requested.
Complete required trainings and certifications, use approved materials and systems, escalate compliance questions promptly, and conduct activities in accordance with Bayer policies, FDA requirements, OIG guidance, the PhRMA Code, and applicable laws.